Neuroendocrine Cancer: diagnostic dilemmas in July 2010

Translate

Every July, I think back to my diagnosis of advanced Neuroendocrine Cancer in 2010.   I guess one of the reasons I do this is to be thankful that I’m still alive but also, I have a sneaking suspicion that I’m still trying to remember small detail from that period.  It had felt surreal ever since 8th July when the secondary care investigating doctor sent me for a CT scan leading to a biopsy on 19th July. 

That scan was to uncover some shocking detail of what had been going on inside my body, with no grand announcement, just something chipping away over the years.  My diagnostic triggers were incidental in many ways and a reaction to me telling a GP Nurse that I thought I’d lost a bit of weight.  I still feel lucky that the Nurse thought to investigate further.

Scans are great at detecting abnormalities but alone they normally cannot tell which type of cancer you have.  But they very often are the trigger for completing a diagnosis by narrowing down the list of possibilities by enabling focus.  Nonetheless, the wording of my very first CT scan was worrisome.  It’s worth remembering that radiologists report what they see, they are not normally there to formally diagnose, although their input is totally key to the investigations.  As they are doctors, they can suggest possibilities using their own experience.  As you know many NET primaries are hard to see and small intestine NETs can often be particularly difficult. 

However, and I say this in hindsight, if I read someone else’s diagnostic scan today and read “mass in the root of the mesentery”, I would immediately be suspicious of that being a small intestine NET case as that is a common presentation for this type of NET.  And that is exactly what it said on my very first diagnostic scan completed on 8th July 2010 even though the “bowel” was said to appear normal (along with the pancreas, kidneys, spleen, lungs and mediastinum).

The radiologist also confirmed I had at least 6 enhancing lesions on my liver measuring up to 6cm and that they were not typical of hemangiomas (benign lesions).  One of the most worrying additions to the report was the “abnormal rind of tissue surrounding the aorta extending distally from below the renal vessels”.  That was pretty scary to me at the time as I knew the aorta was a critical blood vessel.  This issue was later described as retroperitoneal fibrosis. It still worries me today and is covered by this article – click here.

As if I didn’t have enough jigsaw pieces to play with, I had a concurrent issue going on prior to my diagnosis.  I was seeing doctors about a hydrocele, and I had an appointment to repair that on 15th July 2010 but that plan was interrupted by my NET discovery and subsequent treatment.  I eventually got that hydrocele repaired in Sep 2011. However, the radiologists picked up this hydrocele on 8th July and suggested the possibility of a teratoma without realising my doctors had discounted this possibility.  I don’t have an issue with the suggestion, the radiologist was being thorough. I wrote about this issue – read more by clicking here.

The radiologist also mentioned “extensive lymphadenopathy” (swollen lymph nodes) and suggested my presentation was “consistent with lymphoma or adenocarcinoma” as a possibility. It was neither in the end (note: lymphoma can also present in the small intestine – who knew!).  Despite the usefulness of scans, “tissue is the issue”, and I was to have a biopsy on the liver on 19th July.  Prior to the biopsy, they had no inkling the biopsy would confirm a NET thus why no nuclear imaging specific to NET was suggested at this point.  Clearly, it was something I eventually got done.  The CT scan summarised that “there was almost certainly malignant disease surrounding the aorta, in the root of the mesentery and scattered throughout the liver”. Two out of three were correct, the retroperitoneal fibrosis surrounding the aorta was later found to be benign tissue (thankfully) but I can honestly say that issue scares me more than the NET as it’s not just about malignancy, it’s also about a serious threat to key vessels. That threat still lingers today. 

After the scan, I got a gazillion blood tests.  Bearing in mind they had no idea this was a NET case, I did not get Chromogranin A or 5HIAA at this point, this was to come later. 

None of the above can be considered a misdiagnosis, it is a normal clinical practice to look at the differentials ahead of collecting tissue. The biopsy took place on 19th of July, and I had a terrible time throughout the procedure with pain and general discomfort plus some anxiety.  The interventional radiologist took 3 core biopsies from my largest liver tumour.  I had mild anesthesia administered and at the time, I (or they) did not know I had carcinoid syndrome, which was to be found out later.  I’ll never find out if there was a connection with my very uncomfortable biopsy and my carcinoid syndrome, so I try to put that to the back of my mind. Five days later and 48 hours before my Oncologist meeting, there was an incident that led me to be admitted to A&E (ER) but you can read about that in “48 hours before diagnosis” (click here).

Disclaimer

I am not a doctor or any form of medical professional, practitioner or counsellor. None of the information on my website, or linked to my website(s), or conveyed by me on any social media or presentation, should be interpreted as medical advice given or advised by me.  Neither should any post or comment made by a follower or member of my private group be assumed to be medical advice, even if that person is a healthcare professional as they are not members of the private group or followers of my sites in any official capacity.  Please also note that mention of a clinical service, trial/study or therapy does not constitute an endorsement of that service, trial/study or therapy by Ronny Allan, the information is provided for education and awareness purposes and/or related to Ronny Allan’s own patient experience. This element of the disclaimer includes any complementary medicine, non-prescription over the counter drugs and supplements such as vitamins and minerals.

Subscribe to my newsletter

Thanks for reading.

Ronny

I’m also active on Facebook. Like my page for even more news. Help me build up my new site here – click here and ‘Like’

Sign up for my newsletters – Click Here

Disclaimer

My Diagnosis and Treatment History

Follow me on twitter

Check out my online presentations

Check out my WEGO Health Awards

Like my new awareness page – click here or on the photo.  (Like rather than follow please!)


Remember ….. in the war on Neuroendocrine Cancer, let’s not forget to win the battle for better quality of life!

patients included

Please Share this post for Neuroendocrine Cancer awareness and to help another patient

 
 
 

Curtis Crump: “If I’m going down, it won’t be without a fight.”

Curtis Crump: Credit MD Anderson Cancer Center Curtis Crump has an amazing story to tell.  Given 6 months to live, he refused to accept that

Read More »

The trouble with the NET is that it can spread ……. false hope

Certain popular ideas about how cancer starts and spreads – though scientifically wrong, can seem to make sense, especially when those ideas are rooted in

Read More »

Survival Outcomes in Metastatic Gastroenteropancreatic Neuroendocrine Tumor Patients receiving Concomitant 225Ac-DOTATATE Targeted Alpha Therapy and Capecitabine: A Real-world Scenario Management Based Long-term Outcome Study

Introduction I’ve written about both 225Ac-DOTATATE targeted alpha therapy (TAT) and Capecitabine before but never as a concomitant pair (combo). So, when this Indian study

Read More »

12 years – I’m still here!

I finally made 12 years since I was diagnosed on 26th July 2010.  A milestone I was not certain at the time I would reach. 

Read More »

Neuroendocrine Cancer: turn surveillance into a positive

It’s hard to be positive when you don’t know how you’re doing. The only way to know how you’re doing is to get professional surveillance.

Read More »

Assessment of Clinical Response Following Atezolizumab and Bevacizumab Treatment in Patients With Neuroendocrine Tumors: A Nonrandomized Clinical Trial

Background Well differentiated NETs have been described as an “immunological desert” in recent years mainly due to the poor response rate data coming out of

Read More »

Neuroendocrine Cancer: diagnostic dilemmas in July 2010

Every July, I think back to my diagnosis of advanced Neuroendocrine Cancer in 2010.   I guess one of the reasons I do this is to

Read More »

CT scan findings in the COVID era: Ground Glass Opacities (GGO)

The COVID-19 pandemic filled our vocabularies with more medical terms than most of us would ever hear about, but some were familiar.  It soon became

Read More »

Me and the other big C – June/July 2022

Recently, Chris and I felt lucky not to have caught covid since the pandemic started in early 2020. That said, not that we would know

Read More »

3 thoughts on “Neuroendocrine Cancer: diagnostic dilemmas in July 2010

  • Kelly Duggan

    Every time I read your blog I get the most information. I am so grateful for your dedication to education and advocacy. Once again, thank you Ronny 🙂

  • Bruce G. Schneider

    Anniversary awareness does occupy one’s mind. For me, this July.I’d the year anniversary of my lanreotide injections.( my 13th is due this afternoon.)
    My other anniversary will be Nov 13th- 5 years after my pancreatic cancer operation.

I love comments - feel free!

%d bloggers like this: